Microangiopathic hemolytic anemia (MAHA) as paraneoplastic syndrome in metastasized signet ring cell carcinomas: Case reports and review of the literature
Poorly differentiated adenocarcinoma with signet-ring cells of the Vater's ampulla, without jaundice but with disseminated carcinomatosis
Nabeshima S, Kishihara Y, Nabeshima A et al. Poorly differentiated adenocarcinoma with signet-ring cells of the Vater's ampulla, without jaundice but with disseminated carcinomatosis. Fukuoka Igaku Zasshi 2003; 94: 235-240
Microangiopathic hemolytic anemia associated with consumption coagulopathy in a patient with disseminated carcinoma
Joseph RR, Day HJ, Sherwin RM et al. Microangiopathic hemolytic anemia associated with consumption coagulopathy in a patient with disseminated carcinoma. Scand J Haematol 1967; 4: 271-282
Microangiopathic hemolytic anemia in metastatic carcinoma: Report of eight cases
Lohrmann HP, Adam W, Heymer B et al. Microangiopathic hemolytic anemia in metastatic carcinoma: report of eight cases. Ann Intern Med 1973; 79: 368-375
Hemolytic syndrome in a patient with gastric adenocarcinoma: Partial recovery of renal function after gastrectomy
Marcos OO, Escuin E, Miguel JL et al. Hemolytic syndrome in a patient with gastric adenocarcinoma: partial recovery of renal function after gastrectomy. Clin Nephrol 1985; 24: 265-268
Thrombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agents
Murgo AJ. Thrombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agents. Seminars in Haematology 1987; 24: 161-177
Diffuse bone metastasis with hematologic disorders from gastric cancer: Clinicopathological features and prognosis
Tsuyoshi E, Hideo B, Akinobu T et al. Diffuse bone metastasis with hematologic disorders from gastric cancer: clinicopathological features and prognosis. Oncology reports 1999; 6: 601-605